×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SPRY – ars pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SPRY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/9
12:22 pm
spry
ARS Pharma (SPRY) Gains China Approval for Neffy, Roth Reiterates Buy Rating [Yahoo! Finance]
Low
Report
ARS Pharma (SPRY) Gains China Approval for Neffy, Roth Reiterates Buy Rating [Yahoo! Finance]
12/30
08:12 am
spry
ARS Pharmaceuticals announces NMPA approval for neffy 2 mg [Yahoo! Finance]
Low
Report
ARS Pharmaceuticals announces NMPA approval for neffy 2 mg [Yahoo! Finance]
12/29
08:12 am
spry
neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis) [Yahoo! Finance]
Low
Report
neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis) [Yahoo! Finance]
12/29
08:00 am
spry
neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)
Low
Report
neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)
12/1
01:35 am
spry
How Recent Developments Are Shaping the Story for ARS Pharmaceuticals According to Analysts [Yahoo! Finance]
Low
Report
How Recent Developments Are Shaping the Story for ARS Pharmaceuticals According to Analysts [Yahoo! Finance]
11/26
08:28 am
spry
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Low
Report
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
11/26
08:00 am
spry
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
Low
Report
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
11/22
07:57 am
spry
ARS Pharmaceuticals (NASDAQ:SPRY) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Medium
Report
ARS Pharmaceuticals (NASDAQ:SPRY) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Date
Time
Symbol
Company Name
Action
%Chg
11/10/2025
06:00 am
SPRY
ars pharmaceuticals, inc.
MISS
Report
-1.1%
ars pharmaceuticals, inc.
8/13/2025
07:00 am
SPRY
ars pharmaceuticals, inc.
MISS
Report
-9.9%
ars pharmaceuticals, inc.
5/14/2025
07:00 am
SPRY
ars pharmaceuticals, inc.
IN-LINE
Report
-9.8%
ars pharmaceuticals, inc.
Date
Time
Symbol
Headline
Impact
1/5
04:28 pm
spry
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Scott Kathleen D.
Low
Report
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Scott Kathleen D.
1/5
04:27 pm
spry
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Karas Eric
Low
Report
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Karas Eric
1/5
04:25 pm
spry
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Fitzpatrick Alexander A
Low
Report
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Fitzpatrick Alexander A
1/5
04:23 pm
spry
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Dorsey Brian
Low
Report
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Dorsey Brian
1/5
04:22 pm
spry
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Chakma Justin
Low
Report
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Chakma Justin
1/5
04:21 pm
spry
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Tanimoto Sarina
Low
Report
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Tanimoto Sarina
1/5
04:19 pm
spry
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Lowenthal Richard E
Low
Report
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Lowenthal Richard E
11/14
06:44 pm
spry
Form 4 ARS Pharmaceuticals, For: Nov 13 Filed by: Dorsey Brian
High
Report
Form 4 ARS Pharmaceuticals, For: Nov 13 Filed by: Dorsey Brian
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: